Sensitivity encoding for fast 1H MR spectroscopic imaging water reference acquisition

Purpose: Accurate and fast 1H MR spectroscopic imaging (MRSI) water reference scans are important for absolute quantification of metabolites. However, the additional acquisition time required often precludes the water reference quantitation method for MRSI studies. Sensitivity encoding (SENSE) is a successful MR technique developed to reduce scan time. This study quantitatively assesses the accuracy of SENSE for water reference MRSI data acquisition, compared with the more commonly used reduced resolution technique. Methods: 2D MRSI water reference data were collected from a phantom and three volunteers at 3 Tesla for full acquisition (306 s); 2× reduced resolution (64 s) and SENSE R = 3 (56 s) scans. Water amplitudes were extracted using MRS quantitation software (TARQUIN). Intensity maps and Bland‐Altman statistics were generated to assess the accuracy of the fast‐MRSI techniques. Results: The average mean and standard deviation of differences from the full acquisition were 2.1 ± 3.2% for SENSE and 10.3 ± 10.7% for the reduced resolution technique, demonstrating that SENSE acquisition is approximately three times more accurate than the reduced resolution technique. Conclusion: SENSE was shown to accurately reconstruct water reference data for the purposes of in vivo absolute metabolite quantification, offering significant improvement over the more commonly used reduced resolution technique. Magn Reson Med 73:2081–2086, 2015. © 2014 The Authors. Magnetic Resonance in Medicine Published by Wiley Periodicals, Inc. on behalf of International Society of Medicine in Resonance.

[1]  J. Shih,et al.  Proton magnetic resonance spectroscopy predicts survival in children with diffuse intrinsic pontine glioma , 2011, Journal of Neuro-Oncology.

[2]  David Bonekamp,et al.  Quantitative SENSE-MRSI of the human brain. , 2010, Magnetic resonance imaging.

[3]  B D Ross,et al.  Absolute Quantitation of Water and Metabolites in the Human Brain. I. Compartments and Water , 1993 .

[4]  Filip Jiru,et al.  Spectroscopic imaging: basic principles. , 2008, European journal of radiology.

[5]  P Mansfield,et al.  Spatial mapping of the chemical shift in NMR , 1983, Magnetic resonance in medicine.

[6]  Theodoros N. Arvanitis,et al.  Short echo time single voxel 1H magnetic resonance spectroscopy in the diagnosis and characterisation of pineal tumours in children , 2011, Pediatric blood & cancer.

[7]  P. Boesiger,et al.  SENSE: Sensitivity encoding for fast MRI , 1999, Magnetic resonance in medicine.

[8]  Gioacchino Tedeschi,et al.  High Speed 1H Spectroscopic Imaging in Human Brain by Echo Planar Spatial‐Spectral Encoding , 1995, Magnetic resonance in medicine.

[9]  D. Louis Collins,et al.  Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy , 1996, Nature Medicine.

[10]  Jens Frahm,et al.  Clinical proton MR spectroscopy in central nervous system disorders. , 2013, Radiology.

[11]  Sairam Geethanath,et al.  Compressive sensing could accelerate 1H MR metabolic imaging in the clinic. , 2012, Radiology.

[12]  Kiyohiro Houkin,et al.  In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard. , 2004, Magnetic resonance imaging.

[13]  Andrew C Peet,et al.  MR spectroscopy-based brain metabolite profiling in propionic acidaemia: metabolic changes in the basal ganglia during acute decompensation and effect of liver transplantation , 2011, Orphanet journal of rare diseases.

[14]  Theodoros N. Arvanitis,et al.  Magnetic resonance spectroscopy metabolite profiles predict survival in paediatric brain tumours , 2013, European journal of cancer.

[15]  Theodoros N. Arvanitis,et al.  A constrained least‐squares approach to the automated quantitation of in vivo 1H magnetic resonance spectroscopy data , 2011, Magnetic resonance in medicine.

[16]  Theodoros N. Arvanitis,et al.  Identification and characterisation of childhood cerebellar tumours by in vivo proton MRS , 2008, NMR in biomedicine.

[17]  G. Kendall,et al.  Regional neonatal brain absolute thermometry by 1H MRS , 2013, NMR in biomedicine.

[18]  Jens Frahm,et al.  Use of phased array coils for a determination of absolute metabolite concentrations , 2005, Magnetic resonance in medicine.

[19]  A. Beckett,et al.  AKUFO AND IBARAPA. , 1965, Lancet.

[20]  S F Keevil,et al.  Absolute metabolite quantification by in vivo NMR spectroscopy: II. A multicentre trial of protocols for in vivo localised proton studies of human brain. , 1998, Magnetic resonance imaging.

[21]  Gabriele Ende,et al.  MR spectroscopy in Alzheimer’s disease: gender differences in probabilistic learning capacity , 2003, Neurobiology of Aging.

[22]  P. Barker,et al.  In vivo proton MR spectroscopy of the human brain , 2006 .

[23]  P. Boesiger,et al.  Trading spectral separation at 3T for acquisition speed in multi spin-echo spectroscopic imaging. , 2006, AJNR. American journal of neuroradiology.

[24]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[25]  G B Matson,et al.  Reduced phase encoding in spectroscopic imaging , 1994, Magnetic resonance in medicine.

[26]  J R Griffiths,et al.  Linear discriminant analysis of brain tumour 1H MR spectra: a comparison of classification using whole spectra versus metabolite quantification , 2007, NMR in biomedicine.

[27]  Z P Liang,et al.  A generalized series approach to MR spectroscopic imaging. , 1991, IEEE transactions on medical imaging.

[28]  Sabine Van Huffel,et al.  Reproducibility of rapid short echo time CSI at 3 tesla for clinical applications , 2013, Journal of magnetic resonance imaging : JMRI.

[29]  Frederik Barkhof,et al.  Longitudinal absolute metabolite quantification of white and gray matter regions in healthy controls using proton MR spectroscopic imaging , 2014, NMR in biomedicine.

[30]  A. Sorensen,et al.  Magnetic resonance as a cancer imaging biomarker. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  Franklyn A Howe,et al.  1H MR spectroscopy of brain tumours and masses , 2003, NMR in biomedicine.

[32]  Theodoros N. Arvanitis,et al.  The value of magnetic resonance spectroscopy in tumour imaging , 2008, Archives of Disease in Childhood.

[33]  Michael D Noseworthy,et al.  Intraindividual variability of striatal (1)H-MRS brain metabolite measurements at 3 T. , 2006, Magnetic resonance imaging.

[34]  K P Pruessmann,et al.  Sensitivity‐encoded spectroscopic imaging , 2001, Magnetic resonance in medicine.

[35]  L. Astrakas,et al.  Noninvasive Magnetic Resonance Spectroscopic Imaging Biomarkers to Predict the Clinical Grade of Pediatric Brain Tumors , 2004, Clinical Cancer Research.